Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by <i>Helicobacter pylori</i> and Its Effect on Gastrointestinal Flora

<div>RACS attenuated <i>H</i>. <i>pylori</i>-induced histological and ultrastructural damages. (a) Typical microscopic images by HE staining of gastric mucosa: (A) natural control group (NC), (B) HP model group (HP), (C) standard triple therapy group (RAC), (D) standard triple therapy+sucralfate group (RACS), and (E) bismuth-containing quadruple therapy group (RACB). Scale bar: 200 <i>μ</i>m. (b) Transmission electron micrograph images: (A) NC, (B) HP, (C) RAC, (D) RACS, and (E) RACB. Scale bar: 2 <i>μ</i>m.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by <i>Helicobacter pylori</i> and Its Effect on Gastrointestinal Flora 

Figure 1 | Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by Helicobacter pylori and Its Effect on Gastrointestinal Flora 